Dr Nataliya Uboha is an Associate Professor at the University of Wisconsin, Department of Medicine, Division of Hematology and Oncology and a member of Carbone Cancer Center (UWCCC). Her clinical and research activities focus on upper GI cancers. She has extensive clinical trial experience, with a particular emphasis on phase 1 and biomarker based clinical studies. She is a Faculty Leader for the Cancer Therapy Discovery & Development (Phase I) Program at UWCCC. She is a co-leader and founder of the Basket Disease Oriented Team at UWCCC, which has a specific focus on biomarker based trials across disease types. Dr Uboha has a number of regional and national leadership roles. She serves on the board of Wisconsin Association of Hematology and Oncology. She is a co-chair for the GI Cancer Research Group in Big 10 Cancer Research Consortium. She chairs the Upper GI working group at ECOG-ACRIN and serves on the National Cancer Institute Upper GI Taskforce as an ECOG representative.

Dr Nataliya Uboha has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Consulting: QED, Taiho Inc., Incyte, AstraZeneca, Pfizer, Boston Gene, Helsinn
Research Funding: Taiho Inc, Ipsen, EMD Serono
Long position holdings: Natera, Exact Sciences